Skip to Main Content
Skip Nav Destination
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

In hemolytic anemia, and above all during the perinatal age, the blood and bone marrow display an increased erythroblastic proliferation which Schridde (1910) considers as a reactional phenomenon and Rautmann (1912) as a nosologic entity: erytroblastic disease. The pathological morphology of the nuclei of the normoblasts was illustrated by Introzzi (1926), Diamond (1932), Blackfan and Baty (1932). Lehndorff (1934) considers it due to a mutation.Critical study of the literature and the experiments performed by the author have led to the following conclusions:1.In normally maturing erythroblasts, with dense and sometimes pyknotic nucleus, this is rounded and expelled “in toto” without appreciable deformation and with no fragmentation.2.The normoblasts with twin nuclei observed in various pathological states, especially during hemolytic anemia of the perinatal age, are pathological forms.3.At the present stage of our knowledge, Lehndorff’s hypothesis is not acceptable regarding a special erythroblastic line — para-erythroblasts — produced by mutation of the genes controlling the morphology of blood cells.4.It appears more likely that the nuclear deformation is produced as the consequence of an antigen-antibody humoral conflict. The immunizing proteins: maternal antibodies anti-Rh or auto-antibodies, penetrate the normoblasts and, there, come into contact with the respective specific antigens.A consequence of the immunizing conflict is that partial reduction of the surface tension occurs in the nucleo-cytoplasmic interphase which leads to the formation of “shoots” and the transformation of the normoblastic nucleus into the pathological form of paraerythroblasts.

Send Email

Recipient(s) will receive an email with a link to 'International Society of Blood Transfusion7th Congress, Rome, September 1958: Proceedings > 835a - 836: A Study of the Mechanisms of Formation of Para-Erythroblasts' and will not need an account to access the content.

Subject: International Society of Blood Transfusion7th Congress, Rome, September 1958: Proceedings > 835a - 836: A Study of the Mechanisms of Formation of Para-Erythroblasts

(Optional message may have a maximum of 1000 characters.)

×
Close Modal

or Create an Account

Close Modal
Close Modal